News
ECG247 in Saudi Arabia
"We are delighted to partner with AppSens and introduce their cutting-edge cardiac solution, ECG247, to the Saudi market. This partnership
Editorial in EP Europace regarding AF screening with ECG247
Moving the boundaries of AF screening, not at least in terms of combining digital advertising and recruitment with a
Fully digital self-screening for atrial fibrillation with ECG247
This fully digitalized self-screening procedure for AF demonstrated excellent feasibility. The number needed to screen was 45 to detect one unrecognized case of AF in subjects at risk for stroke.
New ECG247 app and portal
New version of the ECG247 app Download for free from the AppStore and Google Play. Same name as
TEDx talk about atrial fibrillation, clinical studies and ECG247
TEDx talk about ECG247
The Norwegian atrial fibrillation self-screening trial (NORSCREEN)
Large AF screening study with ECG137
ECG247 to the final of the Healthcare Innovation World Cup 2022
Selected from >300 health technology products from around the world
Team Uno-X and ECG247
High ECG quality during training
One of the most promising healthcare startups and scaleups in Norway
One of the most promising healthcare startups and scaleups in Norway
Bluetooth LE wearable ECG heart monitor detects cardiac rhythm disorders to identify risk of stroke
Nordic Semiconductor today announces that AppSens, a Lillesand, Norway-based medical technology manufacturer, has selected Nordic’s nRF52832 Bluetooth® Low Energy (Bluetooth LE)
ISO13485 certified
ISO13485 confirms high quality in all stages
